SNYN

MX$909.34

▲+2.79%

wb_incandescent Backtest

Stock

Sanofi

Official Company Name: Sanofi

Stock Symbol: SNYN

Stock Market: Mexican Stock Exchange - BMV

Currency: Mexican peso - MXN

business Sanofi Company Profile

SNYN Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▼-13.40%

file_download

Daily closing prices, with moving averages and volumes - Mexican peso (MXN)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Sanofi, along with its subsidiaries, is involved in the research, development, manufacture, and marketing of various therapeutic solutions. It operates in three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. It offers a wide range of products for specialty care, diabetes, cardiovascular issues, and provides vaccines for various diseases, consumer healthcare products, wellness, probiotics, digestive, and nutritional products.

business Sanofi Company Profile

SNYN Stock Data

Open MX$909.34
High MX$909.34
Low MX$909.34
Close MX$909.34
Volume 1,048
Previous Close MX$884.68
1-Day Change 24.66
1-Year Change -140.66
Average Daily Volume 1,372
52-Week High MX$1,111.00
52-Week Low MX$718.84
warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.